Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline for Serious VRE or MRSA Infections
NCT00079976Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2003
- Primary completion
- Jun 2005
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of tigecycline in Enterococcus infection and Staphylococcus aureus infection (3 arms), sponsored by Pfizer. Primary endpoint: Clinical Response. Started Oct 2003; status: completed.
02
Drugs
tigecycline
03
Conditions
Enterococcus infectionStaphylococcus aureus infection
Beyond the preview
Go deeper on NCT00079976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079976.